-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The clinical research industry is mainly composed of sponsors, CROs, SMOs and hospitals
The capital market is the industry engine, driving the development of China's biopharmaceutical industry
0 1
CRO:
Large and small CRO, each has its own way of living
There are many CROs, large and small, on the market, each with its own merits, or in other words, each has its own way of working
Large-scale international CROs still dominate the group and continue to grow bigger through mergers and reorganizations
Under the operation of capital, some CROs already serve as investors
In addition, some CROs are deeply involved in the relationship with the sponsor, and some CROs are deeply involved in the relationship with the hospital, thereby gaining a competitive advantage in the market
With the unprecedented fierce competition in the clinical operation business, some CROs have begun to develop businesses with a small total amount but higher profits, such as independent third-party inspections, central laboratories, centralized reading, pharmacovigilance, medical supervision, medical writing, data management and statistical analysis
In short, in the case of a surge in the biopharmaceutical industry, CROs, large and small, have a better life
0 2
Sponsor:
Outsourcing? Self-built? Double insurance?
Outsource or do it yourself? This is a question that the sponsor has repeatedly thought about
After the sponsors outsource the project to the CRO, they are often dissatisfied with the performance of the CRO
But building a team by yourself is not easy
Due to the continuous increase in clinical research costs, many sponsors simply adopted a "double insurance" strategy.
After some sponsors have established their own strong teams, they become overwhelmed with people, so they go to help other companies to do projects, and they become another form of CRO
The sponsor’s attitude towards clinical research costs is often getting looser: the card was tight at the beginning, and then adapted; later, as long as the project can be done well, money is not a problem
0 3
SMO:
Fragmentation trend, large SMOs are challenged
Large SMOs are increasingly being challenged by small SMOs
The advantage of a large SMO is its wide coverage
The small SMO has a better relationship with the hospital, and the personnel are mainly local personnel and do not need to travel
.
Small SMOs have low cost and low quotation
.
Since the staff are familiar with the hospital, they also have advantages in efficiency and quality
.
Many small SMOs are directly recommended by the main investigator of the hospital or the director of the institution
.
At the same time, more and more hospitals have their own CRC team, which means they have their own SMO
.
Therefore, large-scale SMOs will face more and more challenges, and SMOs tend to be fragmented
.
Now, some SMOs are developing in the direction of patient recruitment
.
It should be noted that patient recruitment is, after all, a gray area.
As the clinical research industry continues to formalize, this area will become narrower and narrower
.
The researcher is the most important part of the recruitment of subjects, and this has not changed
.
0 4
Hospital:
The more attention is paid to clinical research, the faster the development speed
The clinical research center of a hospital is actually the main body of clinical research and the most critical place in clinical research
.
With the abolition of the institutional certification system, the development of clinical research in second-tier cities or the development of small and medium-sized hospitals in first-tier cities has taken shape
.
On the basis of strengthening the training of researchers, non-well-known hospitals with less previous clinical research experience can also conduct high-quality clinical research
.
In fact, those large and well-known hospitals have also been trained step by step by CROs or foreign companies
.
At the same time, the well-developed SMO system in China also creates convenient conditions for training new researchers
.
However, from a macro point of view, most doctors or hospitals are not paying enough attention to clinical research
.
Many doctors still lack scientific research awareness
.
Generally speaking, hospitals that pay more attention to clinical research will develop faster
.
This is related to the scientific research consciousness of the hospital leaders
.
Just like doctors who do well in surgery, they often neglect to publish articles, but the result is that doctors with more articles have higher achievements; doctors who are strong in clinical diagnosis and treatment often ignore clinical research, and doctors who do more clinical research tend to achieve better results.
High
.